Microenvironmental expansion of hematopoietic stem cells (HSCs) is induced by treatment with parathyroid hormone (PTH) or activation of the PTH receptor (PTH1R) in osteoblastic cells; however, the osteoblastic subset mediating this action of PTH is unknown. Osteocytes are terminally differentiated osteoblasts embedded in mineralized bone matrix but connected with the marrow. Activation of PTH1R in osteocytes increases osteoblastic number and bone mass. To establish whether osteocyte-mediated PTH1R signaling expands HSCs, we studied mice expressing a constitutively active PTH1R in osteocytes (TG mice). Osteoblasts, osteoclasts, and trabecular bone were increased in TG mice without changes in marrow phenotypic HSCs or HSC function. Progressively, TG mice had increased trabecular bone but decreased HSC function. In severely affected TG mice, phenotypic HSC were decreased in the marrow but increased in the spleen. TG osteocytes had no increase in signals associated with microenvironmental HSC support and the spindle-shaped osteoblastic cells increased with PTH treatment were not present in TG bones. These findings demonstrate that activation of PTH1R signaling in osteocytes does not expand marrow HSCs, which are instead decreased in TG mice. Therefore, osteocytes do not mediate the HSC expansion induced by PTH1R signaling. Further, osteoblastic expansion is not sufficient to increase HSCs.
INTRODUCTION
To survive throughout the life of an individual, hematopoietic stem cells (HSCs) must balance self-renewal and differentiation 1 . This essential regulation of stem cells is thought to be determined at least in part by the environment, or niche, in which these cells reside Recently, it has been demonstrated that PTH stimulates osteocytes, where activation of PTH1R signalling down-regulates expression of the Wnt antagonist Sclerostin 6 . This effect of PTH on Sclerostin has also been demonstrated in For personal use only. on April 20, 2017 . by guest www.bloodjournal.org From postmenopausal women treated with PTH 7 , suggesting that Sclerostin downregulation may be an important mediator of the bone anabolic action of PTH. Using an in vivo model in which a constitutively active PTH1R is targeted to osteocytes (DMP1-caPTH1R mice, hereafter named TG), we demonstrated that PTH-dependent signals in osteocytes control bone mass and bone remodeling 8 . Osteocytes are former osteoblasts buried into bone matrix but connected to the endosteum via cytoplasmic processes 9 , which sense mechanical stimuli and regulate both osteoblastic and osteoclastic numbers 10 . It was unknown whether osteocytes affect hematopoiesis and/or HSCs. In the current study we examined whether signalling downstream of the PTH1R in osteocytes supports the expansion of HSCs by analyzing in detail the hematopoietic phenotype of TG mice.
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METHODS

Generation of TG mice
DMP1-caPTH1R mice were generated using a DNA construct encoding the H223R mutant of the human PTH1R, as previously described 8 .
Gene Expression Studies
Total RNA was purified from tissues using Ultraspec Reagent (Biotecx Laboratories, Houston, TX) according to manufacturer's instructions. For
Quantitative RT-PCR, purified total RNA was reverse-transcribed using a High Capacity cDNA Archive Kit (Applied Biosystems, Foster City, CA). Gene expression was analyzed in triplicates by quantitative PCR using the ΔCt method as previously described 11, 12 . Primer probe sets were designed using the Assay Design Center of Roche Applied Science (Indianapolis, IN), and were as follows:
for CXCL-12: forward primer: ctgtgcccttcagattgttg, reverse primer: ctctgcgccccttgttta; Ang-1: forward primer: cggatttctcttcccagaaac, reverse primer: tccgacttcatattttccacaa; IL-7: forward primer: cgcagaccatgttccatgt, reverse primer:
tctttaatgtggcactcagatgat; IL-6: forward primer gctaccaaactggatataatcagga, reverse primer ccaggtagctatggtactccagaa; V-CAM1: forward primer: tggtgaaatggaatctgaacc, reverse primer: cccagatggtggtttcctt; and ribosomal protein S2 (used as house-keeping gene): forward primer: cagaatggtaggaaggtcacg, reverse primer: gatcctgctctggaaatcgt.
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Histology and Immunohistochemistry
Harvested hindlimbs were fixed in 10% neutral buffered formalin for 48 hours, decalcified in 14% Ethylenediaminetetraacetic acid (EDTA, pH 7.2) for 14 days, and processed as described 8, 13 . Histological sections (4µm thickness) were stained with Hematoxylin and Eosin to visualize morphology. For immunohistochemistry, all slides were deparaffinized, rehydrated to PBS (pH 
Light Microscopy
Histology slides were viewed at room temperature with a CKX41 upright microscope (Olympus, Tokyo, Japan). Objectives used were UPlan Fl 20x/0.50, UPlan Fl 40x/0.65 and UPlan FLN 60x/0.90 (Olympus). All images were obtained with a SPOT Insight digital microscope camera and Spot 4.7 software (SPOT imaging Solutions, Diagnostics Instruments, Sterling Heights, MI, USA).
Micro-CT Analysis
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Peripheral blood cell analysis
Prior to euthanasia, 200ul of blood obtained by mandibular venous plexus sampling was run through a CBC-DIFF Veterinary Hematology System (HESKA) to obtain blood cell counts.
Flow Cytometric Analysis
Right hindlimbs (one femur and tibia for each individual mouse) and spleens were harvested from TG mice and wildtype (WT) littermates or WT mice treated with PTH. Spleens were entirely collected. Whole bone marrow was isolated either by crushing the tibia and femur with a mortar and pestle in 10ml of PBS with 2% FBS and filtering through a 40 micron mesh, or by cutting both ends of the tibia and femur and flushing the BM with a 25G needle before filtering (WT and TG littermates were always processed at the same time and using the same method). Red blood cells (RBC) were eliminated from samples by incubating them in RBC lysis buffer (156mM NH 4 Cl, 127μM EDTA, 12mM NaHC 3 ) for 5 minutes at room temperature. Hematopoietic Stem and Progenitor Cells (HSPCs) were identified by the phenotypic markers lineage-sca-1+ c-kit+ (LSK). DAPI (Invitrogen) was used to determine viability of analyzed cells using control viable and dead cells. LSK cells were further subdivided into LT-HSC and 
Competitive Repopulation Assay
Whole marrow from TG and WT sex-matched littermates was obtained simultaneously to the phenotypic data presented for the same cohort of mice, 
PTH injections
Rat PTH (1-34) was purchased from Bachem (Torrance, CA) and resuspended in water to 400μg/ml. This solution was diluted 1:100 in sterile 0.9% Sodium Chloride solution and administered intraperitoneally to 8-10 week old C57/BL6 male mice at 40μg/kg three times daily for 10 days. Mice were sacrificed 15 hours after the last injection. The left hind limb was harvested for histology.
Statistical analysis
For quantitative assays, treatment groups were reported as mean ± standard error of the mean (SEM). T-tests or ANOVA with Bonferroni's post-test were performed using GraphPad Prism version 4.01 for Windows, GraphPad Software. Statistical significance was established at P≤0.05.
RESULTS
Targeted expression of a constitutively active PTH1R in osteocytes increases trabecular bone and osteoblastic cells
To establish if activation of PTH signaling in osteocytes expands HSCs, we studied TG mice in which a constitutively active PTH1R is targeted to osteocytes by the 8 kilobase fragment of the dentin matrix protein-1 (DMP1) gene promoter ( fig. 1A ). Strong expression of the transgene in both long bones and vertebrae was confirmed in TG mice as early as at 3.5 weeks of age ( fig.   1B ). At this time point, TG mice had a large increase in mineralized trabecular bone, which could be easily appreciated both in histological sections of the long bones ( fig. 1C-F) and by micro CT analysis ( fig. 1G ). The net increase in bone in the TG mice is due to exuberant bone formation and increased osteoblastic cell numbers, not due to defective osteoclastogenesis or bone resorption, as has previously been demonstrated 8 . We chose this early time point for initial hematopoietic analysis of TG mice.
In vivo activation of PTH receptor signaling in osteocytes does not increase bone marrow phenotypic HSCs, spleen weight or extramedullary hematopoiesis
The hematopoietic phenotype was studied in 3.5 week-old male and female mice. In TG mice, there were no changes in peripheral blood counts (Supplemental fig.1 ), bone marrow cellularity ( fig. 2D) Therefore, these results suggest that potential Sclerostin-targeted therapies 21, 22 would not achieve HSC expansion in spite of their osteogenic actions.
The interpretation of the current data relies heavily upon specific osteocytic expression of the transgene. The fragment of the DMP1 gene promoter employed in TG mice has been demonstrated to direct transgene expression specifically to newly embedding and embedded osteocytes 10, 23, 24, 8 .
The mutated human PTH1R used, which was first described in the setting of Jansen metaphyseal chondrodysplasia 25, 26 , is the same mutated receptor used 5, 35 . Therefore, lack of support of HSCs by a cellular population in the marrow, rather than crowding of the marrow cavity, may explain the migration of immature hematopoietic cells to the spleen, particularly at early time points.
Neutropenia was identified in adult TG mice. This finding may represent early evidence of progressive cytopenias as a result of displacement of phenotypic HSC due to reduction of supportive niches in the marrow. However, the current data cannot exclude a decrease in support of myelopoiesis and myeloid precursors, alone or in addition to the effects on HSCs, due to the microenvironmental changes initiated by osteocyte activation.
PTH-dependent expansion of a population of peritrabecular stromal cells has been described in PTH excess (hyperparathyroidism) 36 , in pharmacologic PTH treatment as well as in 2.3Col1-caPTH1R mice 13, 37, 38 . In spite of robust osteoblastic expansion, this population was not increased in TG mice, a finding consistent with the activation and expansion of mature osteoblasts and osteocytes in this model. Definition of these spindle cells remains elusive, although much data suggest that they represent an immature osteoblastic 
